PCRX - Pacira BioSciences, Inc. Quarterly EPS earnings growth
Investments in a staff of scientists and physicians ensure steady progress for Pacira BioSciences (PCRX), as evidenced by the shift in quarterly EPS, where the current level is 470.20. Strategic partnerships with clinics are expanding the target market, while improvements in the liposomal delivery of EXPAREL pave the way for new non-opioid analgesics. This synergy of resources and innovation strengthens the business's financial stability.
%20Earnings%20per%20share%20growth%20in%20annualized%20terms%20for%20the%20last%20twelve%20months&width=1200&height=400&colorIndex=0&v=mwejrfjc.e5f-7d7lczk&start=20220704&end=20261113&filename=GURU_Markets_-_PCRX_-_Pacira-BioSciences_-_Earnings-per-share-growth-in-annualized-terms-for-the-last-twelve-months "pacira.com (PCRX): Year-over-year earnings per share growth for the last twelve months from 07/04/2022 to 11/13/2026 | 👁️GURU.Markets👁️")
PCRX (Pacira Corp): analytical breakdowns and indicator data
- share price and expert price forecast:
- market capitalization statistics:
- balance sheet net asset value indicators:
- company liabilities and liquidity data:
- earnings and market multiples details:
PCRX - Net Profit|Future Profit Pacira BioSciences|PCRX - Company Value to Net Income|Forward P/E Multiple Pacira|PCRX - Price/Earnings to Growth Ratio|EV/EBITDA Multiple Pacira|PCRX - Operating income before deduction of amortization|Earnings per share for the last twelve months Pacira BioSciences|PCRX - Net earnings per one share for the last twelve months|Year-over-year earnings per share growth for the last twelve months pacira.com|PCRX - Expected net earnings per share growth this year|Earnings growth forecast for next year Pacira BioSciences
Basic company analysis:Pacira BioSciences, Inc. - PCRX
The Pacira BioSciences (PCRX) EXPAREL non-opioid surgery ecosystem relies on strict FDA regulations and the Medicare reimbursement system. This quarterly EPS trend analysis mathematically compares current earnings per share with target business expansion rates. The metric filters out market noise, revealing the actual monetization efficiency of hospital protocols. This chart allows for the determination of whether revenues align with fundamental growth, which is critical for assessing the fair value of capital.
Competitors of Pacira BioSciences (PCRX)
HLN: Quarterly EPS earnings growth|Kenvue Inc - Year-over-year earnings per one share growth for the last 12 months|VRNA (Verona Pharma Corp) - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months Jyong Bio MENS|Year-over-year earnings per share growth for the last twelve months Ligand Pharmaceuticals (LGND)|AMRX (amneal.com) - Year-over-year earnings per one share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months Perrigo PRGO|ALVO (Alvotech S.A.) - Year-over-year net earnings per share trend for the last twelve months|Liquidia Technologies - Quarterly EPS earnings growth|GLPG - Quarterly EPS earnings growth|ANIP: Quarterly EPS earnings growth|Year-over-year net earnings per share growth for the last 12 months mannkindcorp.com|AMPH (Amphastar Pharmaceuticals, Inc.) - Quarterly EPS earnings growth|ARS Pharmaceuticals Inc (SPRY) - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months Theravance (TBPH)|AQST (Aquestive Corp) - Year-over-year earnings per one share growth for the last 12 months|Quarterly EPS earnings growth SCPH (scPharmaceuticals)|Quarterly EPS earnings growth Tectonic Therapeutic Inc. TECX|TNXP: Year-over-year net earnings per share growth for the last 12 months|Year-over-year earnings per one share growth for the last 12 months SXTC (China SXT Pharmaceuticals)|EPRX: Quarterly EPS earnings growth|BHST (BioHarvest Sciences Inc) - Year-over-year earnings per share growth for the last twelve months|EXOZ (eXoZymes Inc) - Quarterly EPS earnings growth|Oramed Pharma (ORMP) - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months Entera Bio Ltd. (ENTX)|HYFT - Earnings per share growth in annualized terms for the last twelve months|Year-over-year earnings per share growth for the last twelve months ABVC BioPharma Inc ABVC|Year-over-year net earnings per share change for the last twelve months Cumberland Corp (CPIX)|Quantum BioPharma Ltd - Quarterly EPS earnings growth|fibrogen.com (FGEN) - Year-over-year net earnings per share growth for the last 12 months|TELO: Quarterly EPS earnings growth|RANI - Year-over-year net earnings per share change for the last twelve months|SNYR (Synergy CHC Corp.) - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months Rallybio Corp. RLYB|Year-over-year earnings per share growth for the last twelve months Lexaria Bioscience (LEXX)|pulmatrix.com - Year-over-year earnings per share growth for the last 12 months|Quarterly EPS earnings growth PTHL (Pheton Holdings)|APM - Year-over-year net earnings per share growth for the last 12 months|Lyra Therapeutics, Inc - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months impactbiomedinc.com|tnfpharma.com (TNFA) - Year-over-year earnings per share growth for the last twelve months|YCBD - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months PainReform|Auris Medical - Year-over-year net earnings per share trend for the last twelve months|Quarterly EPS earnings growth LIPO|Year-over-year net earnings per share growth for the last 12 months OptiNose Corp OPTN|Year-over-year earnings per share growth for the last twelve months Pieris Pharmaceuticals PIRS|Year-over-year earnings per one share growth for the last 12 months PROC|PTPI: Year-over-year net earnings per share growth for the last 12 months|QLI (Qilian International Holding Group) - Year-over-year earnings per share growth for the last 12 months|ACELYRIN, Inc. (SLRN) - Year-over-year earnings per share growth for the last twelve months|Year-over-year net earnings per share trend for the last twelve months TFFP (TFF Pharmaceuticals, Inc)
